MD
Madrigal Pharma
MDGL·NASDAQW Conshohocken PAFounded 2016430 employees
Mid CapbiotechPublicMetabolicHepatology
Platform: Rezdiffra
Market Cap
$7B
All Drugs
4
Clinical Trials
9
Failed / Terminated
3
FDA Approved
1
Stock Price & Catalysts (MDGL)
Loading MDGL stock data...
Drug Pipeline (4 programs)
| Drug Name | Code | Phase | Trials | Modality | Target | MOA | Indications |
|---|---|---|---|---|---|---|---|
| MDG-4513 | MDG-4513 | Phase 1/2 | 1 | CD3 | Prostate CaMeso | ||
| Rimabrutinib | MDG-1911 | Phase 1/2 | 2 | GPRC5D | PNHEpilepsy | ||
| Ivotuximab | MDG-8667 | Phase 2 | 2 | CD123 | LGSPancreatic Ca | ||
| MDG-611 | MDG-611 | Approved | 4 | CGRP | Endometrial CaAS |
SEC Filings & Financial Documents
Insider Trading Activity
Fetching insider trading data from SEC EDGAR...
Catalyst Events (5)